Ask AI

Breaking New Ground in CRSwNP: Expert Perspectives on Targeting Epithelial Cytokines

Deepen your understanding of chronic rhinosinusitis with nasal polyps (CRSwNP), including the function of epithelial cytokines that lead to inflammation, latest evidence for using biologic therapies to target these cytokines, and identification of patients with CRSwNP who may benefit from treatment with targeted biologics, through expert-written ClinicalThought commentaries, a video module, and downloadable slides. 

Share

Program Content

Events

Activities

Improving Outcomes in CRSwNP
Improving Outcomes in CRSwNP: Understanding Disease Pathogenesis and the Emerging Role of Biologics
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: June 27, 2025

Expires: June 26, 2026

Activities

CRSwNP Roundtable Module 1
Breaking New Ground in CRSwNP: Type 2 Inflammatory Pathways in CRSwNP and the Critical Function of Airway Epithelial Cytokines Roundtable Module 1
Video
Congratulations: You achieved a completion on 04/09/2022

Released: June 20, 2025

Expires: June 19, 2026

CRSwNP Roundtable Module 2
Breaking New Ground in CRSwNP: The Biologics Landscape in CRSwNP Including Emerging Therapeutic Targets Roundtable Module 2
Video
Congratulations: You achieved a completion on 04/09/2022

Released: June 20, 2025

Expires: June 19, 2026

CRSwNP Roundtable Module 3
Breaking New Ground in CRSwNP: Updating CRSwNP Clinical Pathways to Integrate the Latest Therapeutic Advances Roundtable Module 3
Video
Congratulations: You achieved a completion on 04/09/2022

Released: June 26, 2025

Expires: June 25, 2026

Activities

Breaking New Ground in CRSwNP Slides
Breaking New Ground in CRSwNP: Expert Perspectives on Targeting Epithelial Cytokines
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 01, 2025

Expires: June 30, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC in partnership with Snot Force Alliance, Inc.

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca

Partners

Snot Force Alliance, Inc.

ProCE Banner